Spruce Biosciences, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
HealthCap VIII, L.P. has reduced its beneficial ownership in Spruce Biosciences, Inc. to 3.4%, falling below the 5% threshold.
NASDAQ
A group of RiverVest Venture funds and associated individuals have filed an amended Schedule 13D, indicating they collectively ceased to beneficially own more than 5% of Spruce Biosciences, Inc.'s common stock as of January 7, 2025.